Arnett HA & Viney JL, 2014 Immune modulation by butyrophilins.
Nat Rev Immunol
Afrache et al, 2012 The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.
Zhao et al, 2018 Gamma-delta (γδ) T cells: friend or foe in cancer development?
J Transl Med
Lo Presti et al, 2017 Current Advances in γδ T Cell-Based Tumor Immunotherapy.
Silva-Santos B & Strid J, 2017 γδ T cells get adaptive.
Lawand M et al, 2017 Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.
Kabelitz D et al, 2017 Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins.
Tosolini et al, 2017 Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.
Legut M et al, 2015 The promise of cd T cells and the cd T cell receptor for cancer immunotherapy.
Cell Mol Immunol
Gentles A et al, 2015 The prognostic landscape of genes and infiltrating immune cells across human cancers.
Lo Presti et al, 2014 Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.
Schildberg et al, 2016 Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Derré et al, 2010 BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination
J Clin Invest
Prof. René HOET, PhD
A company that delivers innovation
ImCheck has made rapid advances with first-in-class antibodies that are moving towards the clinic, as well as a wealth of exciting antibody discovery programs addressing novel targets in IO and auto-immunity. I am delighted to put my over 20 years’ experience in antibody discovery and development to bring these molecules to patients in medical need.